We are live on
!
Find out more
CC
Caxton Corporation Portfolio holdings
AUM
$4.02M
1-Year Est. Return
256.08%
This Fund
S&P 500
This Quarter
Est. Return
-12.47%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$88.7M
AUM Growth
+$635K
(+0.72%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
17.33%
Top 10 Holdings %
Top 10 Hldgs %
88.06%
Holding
43
New
12
Increased
20
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
+$13.5M |
| 2 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
+$2.23M |
| 3 |
ABDC
Alcentra Capital Corp
ABDC
|
+$1.39M |
| 4 |
Calumet Specialty Products
CLMT
|
+$281K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$237K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alerian MLP ETF
AMLP
|
+$4.53M |
| 2 |
LITS
Lite Strategy Inc
LITS
|
+$2.29M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$244K |
| 4 |
Marker Therapeutics
MRKR
|
+$189K |
| 5 |
KALA BIO
KALA
|
+$97.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.92% |
| 2 | Financials | 4.56% |
| 3 | Consumer Discretionary | 1.07% |
| 4 | Industrials | 1.06% |
| 5 | Communication Services | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moody's
MCO
$89.2B
| $241K | 0.27% |
1,175
+81
| +7% | +$17K |
|
|
27
Calumet Specialty Products
CLMT
$3.73B
| $239K | 0.27% |
+65,689
| New | +$281K |
|
28
Credit Acceptance
CACC
$6.69B
| $238K | 0.27% |
517
+38
| +8% | +$18K |
|
29
Expedia Group
EXPE
$32.3B
| $237K | 0.27% |
1,763
+141
| +9% | +$18.6K |
|
30
Lennar Class A
LEN
$20.2B
| $229K | 0.26% |
+4,239
| New | +$207K |
|
31
Liberty Media Series C
FWONK
$25.6B
| $224K | 0.25% |
+5,571
| New | +$216K |
|
32
Interactive Brokers
IBKR
$40.3B
| $220K | 0.25% |
16,392
+1,580
| +11% | +$19.7K |
|
33
JPMorgan Chase
JPM
$907B
| $218K | 0.25% |
+1,853
| New | +$210K |
|
34
RTX Corp
RTX
$261B
| $216K | 0.24% |
+2,515
| New | +$209K |
|
35
Citigroup
C
$217B
| $214K | 0.24% |
+3,101
| New | +$211K |
|
36
Union Pacific
UNP
$179B
| $209K | 0.24% |
+1,289
| New | +$217K |
|
37
General Motors
GM
$68.6B
| $208K | 0.23% |
+5,545
| New | +$213K |
|
38
FerroAtlántica
GSM
$626M
| $148K | 0.17% |
131,378
+130
| +0.1% | +$182 |
|
|
CBIO
39
Crescent Biopharma
CBIO
$407M
| $115K | 0.13% |
+266
| New | +$171K |
|
|
FSTX
40
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $82K | 0.09% |
5,969
+14
| +0.2% | +$231 |
|
|
41
Alerian MLP ETF
AMLP
$12.7B
| – | – |
-91,949
| Closed | -$4.53M |
|
|
42
Marker Therapeutics
MRKR
$21.8M
| – | – |
-2,392
| Closed | -$189K |
|
|
DRNA
43
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-15,487
| Closed | -$244K |
|
Similar funds
PCM
EAMS
RCP
RA
CGA
HFA
ABA
UOMF
Caxton Corporation's Q3 2019 Portfolio in Review
As of Q3 2019, Caxton Corporation held 43 positions worth $88.7M, up 0.72% from $88M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Caxton Corporation deployed $15.4M of net new capital in Q3 2019, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Satsuma Pharmaceuticals, Inc. Common Stock: 870,820 shares worth $13.1M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 66% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Lite Strategy Inc, an estimated $2.29M trimmed.
- Caxton Corporation's largest Q3 2019 buy was Satsuma Pharmaceuticals, Inc. Common Stock: 870,820 shares worth $13.1M.
- Caxton Corporation added most to Viracta Therapeutics, Inc. Common Stock in Q3 2019, an estimated $2.23M increase.
- Caxton Corporation's biggest Q3 2019 reduction was Lite Strategy Inc, cutting an estimated $2.29M.
- Caxton Corporation fully exited Alerian MLP ETF in Q3 2019, selling an estimated $4.53M.
- Caxton Corporation's ten largest holdings make up 88% of its $88.7M portfolio in Q3 2019.
- Caxton Corporation opened 12 new positions and closed 3 in Q3 2019.
- Caxton Corporation's portfolio value rose 0.72% quarter-over-quarter to $88.7M.
Based on Caxton Corporation's 13F filing for Q3 2019, filed 14 Nov 2019.